Fascin expresion in glial tumors and its prognostic significance in glioblastomas

Neuropathology

Volumn 28, Issue 4, 2008, Pages 382-386

  Gunal, Armagan ^a   Onguru, Onder ^a   Safali, Mukerrem ^a   Beyzadeoglu, Murat ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Astrocytoma; Fascin; Glial tumor; Glioblastoma; Glioma; Immunohistochemistry

Indexed keywords

FASCIN; ACTIN BINDING PROTEIN; CARRIER PROTEIN;

ADULT; AGED; ARTICLE; BRAIN TISSUE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL SURVIVAL; CORRELATION ANALYSIS; GLIOBLASTOMA; GLIOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT REFUSAL; ASTROCYTOMA; BIOSYNTHESIS; BRAIN TUMOR; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY;

ADULT; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; CARRIER PROTEINS; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MICROFILAMENT PROTEINS; MIDDLE AGED; PROGNOSIS;

EID: 44849109087     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2008.00889.x     Document Type: Article

References (26)

1. Adams JC. Roles of fascin in cell adhesion and motility. Curr Opin Cell Biol 2004 16:590 596.
2. Kureishy N, Sapountzi V, Prag S et al. Fascins, and their roles in cell structure and function. Bioessays 2003 24:350 361.
3. Iacobuzio-Donahue CA, Ashfaq R, Maitra A et al. Highly expressed genes in pancreatic ductal adenocarcinomas. Cancer Res 2003 63:8614 8622.
4. Yolder BJ, Tso E, Skacel M et al. The expression of fascin, an actin-bundling motility protein, correlates with hormone receptor-negative breast cancer and a more aggressive clinical course. Clin Cancer Res 2005 11:186 192.
5. Grothey A, Hashizume R, Ji H et al. C-erbB-2/HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines. Oncogene 2000 19:4864 4875.
6. Hashimoto Y, Shimada Y, Kawamura J et al. The prognostic relevance of fascin expression in human gastric carcinoma. Oncology 2004 67:262 270.
7. Zhang H, Xu L, Xiao D et al. Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma. J Clin Pathol 2006 59:958 964.
8. Hashimoto Y, Ito T, Inoue H et al. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma. Clin Cancer Res 2005 11:2597 2605.
9. Pelosi G, Pastorino U, Pasini F et al. Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. Br J Cancer 2003 88:537 547.
10. Pelosi G, Pasini F, Fraggetta F et al. Independent value of fascin immunoreactivity for predicting lymph node metastases in typical and atypical pulmonary carcinoids. Lung Cancer 2003 42:203 213.
11. Adsay V, Baştürk O, Cheng JD et al. Ductal neoplasia of the pancreas: nosologic, clinicopathologic and biologic aspects. Semin Radiat Oncol 2005 15:254 264.
12. Hu W, McCrea PD, Deavers M et al. Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors. Clin Exp Metastasis 2000 18:83 88.
13. Tong GX, Yee H, Chiriboga L et al. Fascin-1 expression in papillary and invasive urothelial carcinomas of the urinary bladder. Hum Pathol 2005 36:741 746.
14. Peraud A, Mondal S, Hawkins C et al. Expression of fascin, an actin-bundling protein, in astrocytomas of varying grades. Brain Tumor Pathol 2003 20:53 58.
15. Roma AA, Prayson RA. Fascin expression in 90 patients with glioblastoma multiforme. Ann Diagn Pathol 2005 9:307 311.
16. Louis D, Ohgaki H, Wiestler O, Cavenee WK, eds. World Health Organization classification of tumours: tumours of the nervous system. Lyon:IARC Press, 2007 14 52.
17. Grothey A, Hashizume R, Şahin AA et al. Fascin, an actin-bundling protein associated with cell motility, is upregulated in hormone receptor negative breast cancer. Br J Cancer 2000 83:870 873.
18. Jawhari AU, Buda A, Jenkins M et al. Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. Am J Pathol 2003 162:69 80.
19. Swierczynski SL, Maitra A, Abraham SC et al. Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays. Hum Pathol 2004 35:357 366.
20. Schmidt MC, Antweiler S, Urban N. Impact of genotype and morphology on the prognosis of glioblastoma. J Neuropathol Exp Neurol 2002 61:321 328.
21. Ohgaki H, Kleihaus P. Population-based studies on incidence, survival rates and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 2005 64:479 489.
22. Hill C, Hunter SB, Brat JD. Genetic markers in glioblastoma: prognostic significance and future therapeutic implications. Adv Anat Pathol 2003 10:212 217.
23. Gudinaviciene I, Pranys D, Juozaityte E. Impact of morphology and biology on the prognosis of patients with gliomas. Medicina 2004 40:112 120.
24. Hilton DA, Penney M, Evans B et al. Evaluation of molecular markers in low grade diffuse astrocytomas: loss of p16 and retinoblastoma protein expression is associated with short survival. Am J Clin Pathol 2002 26:472 478.
25. Tohma Y, Gratas C, Biernat W et al. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. J Neuropathol Exp Neurol 1998 57:684 689.
26. Watanabe K, Tachibana O, Sato K et al. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 1996 6:217 224.